Skip to main content

previous disabled Page of 8
and
  1. Article

    Open Access

    Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality

    To assess cancer-specific mortality (CSM) and other-cause mortality (OCM) rates in patients with rare histological prostate cancer subtypes.

    Carolin Siech, Mario de Angelis in Prostate Cancer and Prostatic Diseases (2024)

  2. Article

    Open Access

    Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis

    Triplet therapy, androgen receptor signaling inhibitors (ARSIs) plus docetaxel plus androgen-deprivation therapy (ADT), is a novel guideline-recommended treatment for metastatic hormone-sensitive prostate canc...

    Akihiro Matsukawa, Pawel Rajwa in International Journal of Clinical Oncology (2024)

  3. No Access

    Article

    Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients

    It is unknown whether the stage of the primary may influence the survival (OS) of metastatic upper tract urothelial carcinoma (mUTUC) patients treated with nephroureterectomy (NU) and systemic therapy (ST). We...

    Simone Morra, Reha-Baris Incesu, Lukas Scheipner, Andrea Baudo in World Journal of Urology (2024)

  4. No Access

    Article

    Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer

    The cT1a vs. cT1b substratification was introduced in 1992 but never formally tested since.

    Lukas Scheipner, Andrea Baudo, Letizia Maria Ippolita Jannello in World Journal of Urology (2024)

  5. No Access

    Article

    Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus

    Up to 15% of patients with locally advanced renal cell carcinoma (RCC) harbors tumor thrombus (TT). In those cases, radical nephrectomy (RN) and thrombectomy represents the standard of care. We assessed the im...

    Pietro Scilipoti, Giuseppe Rosiello, Alessandro Larcher in World Journal of Urology (2024)

  6. No Access

    Article

    Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy

    Radiotherapy (RT) represents a treatment option for small renal masses with proven feasibility and tolerability. However, it has never been directly compared to partial nephrectomy (PN) with cancer-specific m...

    Mario de Angelis, Simone Morra, Lukas Scheipner, Carolin Siech in World Journal of Urology (2024)

  7. No Access

    Article

    The effect of race/ethnicity on cancer-specific mortality after trimodal therapy

    Trimodal therapy (TMT) is the most validated bladder-sparing treatment for organ-confined urothelial carcinoma of the urinary bladder (OC UCUB, namely cT2N0M0). However, it is unknown if barriers to the use of...

    Mario de Angelis, Andrea Baudo in Journal of Racial and Ethnic Health Dispar… (2024)

  8. Article

    Open Access

    Metastasis-directed therapy: new standard or too early to change paradigm?

    Metastasis-directed therapy (MDT) is an emerging treatment strategy for patients with oligometastatic prostate cancer (PCa), particularly for oligorecurrent disease. This review aims to summarize findings from...

    Jakob Klemm, Pawel Rajwa, Marcin Miszczyk in memo - Magazine of European Medical Oncolo… (2024)

  9. Article

    Open Access

    Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

    Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo in Prostate Cancer and Prostatic Diseases (2023)

  10. No Access

    Article

    Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls

    It is unknown whether five-year overall survival (OS) differs and to what extent between testicular germ-cell tumor (TGCT) patients and age-matched male population-based controls.

    Simone Morra, Mattia Luca Piccinelli in International Urology and Nephrology (2023)

  11. Article

    Open Access

    Regional differences in clear cell metastatic renal cell carcinoma patients across the USA

    To test for regional differences in clear cell metastatic renal cell carcinoma (ccmRCC) patients across the USA.

    Lukas Scheipner, Stefano Tappero, Mattia Luca Piccinelli in World Journal of Urology (2023)

  12. No Access

    Article

    Characteristics of incidental prostate cancer in the United States

    Data regarding North-American incidental (cT1a/b) prostate cancer (PCa) patients is scarce. To address this, incidental PCa characteristics (age, PSA values at diagnosis, Gleason score [GS]), subsequent treatm...

    Lukas Scheipner, Reha-Baris Incesu, Simone Morra in Prostate Cancer and Prostatic Diseases (2023)

  13. Article

    Open Access

    Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes

    The present systematic review and network meta-analysis (NMA) compared the current different neoadjuvant chemotherapy (NAC) regimes for bladder cancer patients to rank them.

    Abdulmajeed Aydh, Reza Sari Motlagh, Abdulaziz Alamri in World Journal of Urology (2023)

  14. Article

    Open Access

    Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma

    To evaluate the prognostic value and the clinical impact of preoperative serum cholinesterase (ChoE) levels on decision-making in patients treated with radical nephroureterectomy (RNU) for clinically non-metas...

    Markus von Deimling, David D’Andrea, Benjamin Pradere in World Journal of Urology (2023)

  15. Article

    Open Access

    Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis

    To analyze and summarize the efficacy of immune checkpoint inhibitor (ICI) alone or in combination therapy for renal cell carcinoma (RCC) and urothelial carcinoma (UC) stratified by sex.

    Takafumi Yanagisawa, Tatsushi Kawada, Fahad Quhal in World Journal of Urology (2023)

  16. No Access

    Article

    Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy

    The role of lymph node dissection (LND) in patients with renal cell carcinoma (RCC) is still controversial. However, detecting lymph node invasion (LNI) is key due to prognostic implications and to identify pa...

    Giuseppe Rosiello, Pietro Scilipoti, Alessandro Larcher in World Journal of Urology (2023)

  17. No Access

    Article

    Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities

    It is unknown to what extent overall survival (OS) of organ-confined (T2N0M0) urothelial carcinoma of the urinary bladder (UCUB) patients differs from age- and sex-matched population-based controls, especially...

    Cristina Cano Garcia, Mattia Luca Piccinelli in International Urology and Nephrology (2023)

  18. Article

    Open Access

    Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables

    To test the effect of race/ethnicity on Social Security Administration (SSA) life tables’ life expectancy (LE) predictions in localized prostate cancer (PCa) patients treated with either radical prostatectomy ...

    Christoph Würnschimmel, Luigi Nocera in Journal of Racial and Ethnic Health Dispar… (2023)

  19. No Access

    Article

    Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis

    Combination systemic therapies have become the standard for metastatic hormone-sensitive prostate cancer (mHSPC). However, the effect of age on oncologic outcomes remains unknown. Our aim was to perform a syst...

    Pawel Rajwa, Takafumi Yanagisawa in Prostate Cancer and Prostatic Diseases (2023)

  20. Article

    Open Access

    Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy

    The objective of the study was to test the impact of implementing standard full functional-length urethral sphincter (FFLU) and neurovascular bundle preservation (NVBP) with intraoperative frozen section techn...

    Benedikt Hoeh, Jan L. Hohenhorst, Mike Wenzel, Clara Humke in Journal of Robotic Surgery (2023)

previous disabled Page of 8